|
NUDT16P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.84767822842514E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.62754312436209E-13 |
| Normal-vs-Stage2 |
5.18679543759504E-11 |
| Normal-vs-Stage3 |
3.5527136788005E-15 |
| Normal-vs-Stage4 |
1.63191682389652E-12 |
| Stage1-vs-Stage2 |
9.152200E-01 |
| Stage1-vs-Stage3 |
1.583640E-02 |
| Stage1-vs-Stage4 |
4.002200E-02 |
| Stage2-vs-Stage3 |
1.257000E-01 |
| Stage2-vs-Stage4 |
1.002030E-01 |
| Stage3-vs-Stage4 |
7.007600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63935531816151E-12 |
| Normal-vs-AfricanAmerican |
1.17070000027475E-07 |
| Normal-vs-Asian |
4.68920458018829E-11 |
| Caucasian-vs-AfricanAmerican |
6.053800E-01 |
| Caucasian-vs-Asian |
2.233200E-01 |
| AfricanAmerican-vs-Asian |
7.556800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.97109037162136E-13 |
| Normal-vs-Female |
1.68731695282531E-12 |
| Male-vs-Female |
5.161600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.95110594347625E-12 |
| Normal-vs-Age(41-60Yrs) |
1.82209802801481E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64657176782157E-12 |
| Normal-vs-Age(81-100Yrs) |
3.94540000000498E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.956600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.851800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.643600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.244600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.753400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.195000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.77556999999551E-05 |
| Classical-VS-Follicular |
6.755400E-04 |
| Classical-VS-Other |
8.993400E-01 |
| Classical-VS-Normal |
1.66755498298699E-13 |
| Tall-VS-Follicular |
5.00440000550384E-09 |
| Tall-VS-Other |
2.667800E-02 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
3.676800E-01 |
| Follicular-VS-Normal |
5.68650015964067E-10 |
| Other-VS-Normal |
9.978800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.38953301590072E-12 |
| Normal-vs-N1 |
1.55431223447522E-15 |
| N0-vs-N1 |
7.702200E-03 |
|
|
